Literature DB >> 24096477

MDM2's social network.

R Fåhraeus1, V Olivares-Illana2.   

Abstract

MDM2 is considered a hub protein due to its capacity to interact with a large number of different partners of which p53 is most well described. MDM2 is an E3 ubiquitin ligase, and many, but not all, of its interactions relate directly to this activity, such as substrates, adaptors or bridges, promoters, inhibitors or complementary factors. Some interactions serve regulatory functions that in response to cellular stresses control the localisation and functions of MDM2 including protein kinases, ribosomal proteins and proteases. Moreover, interactions with nucleotides serve other functions such as mRNA to regulate protein synthesis and DNA to control transcription. To perform such a pleiotropic panorama of different functions, MDM2 is subjected to a multitude of post-translational modifications and is expressed in different isoforms. The large and diverse interactome is made possible due to the plasticity of MDM2 and in this review we have listed the MDM2 interactions until now and we will discuss how this multifaceted protein can interact with such a variety of substrates to provide a key intermediary role in different signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24096477     DOI: 10.1038/onc.2013.410

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

Review 1.  MDM2 and mitochondrial function: One complex intersection.

Authors:  Camila Rubio-Patiño; Andrew Paul Trotta; Jerry Edward Chipuk
Journal:  Biochem Pharmacol       Date:  2018-11-01       Impact factor: 5.858

2.  WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5-MDM2-p53 pathway.

Authors:  Yumei Li; Yu Zhou; Bifei Li; Fan Chen; Weiyu Shen; Yusheng Lu; Chunlian Zhong; Chen Zhang; Huanzhang Xie; Vladimir L Katanaev; Lee Jia
Journal:  Oncogene       Date:  2020-01-31       Impact factor: 9.867

3.  Mdm4 supports DNA replication in a p53-independent fashion.

Authors:  Kai Wohlberedt; Ina Klusmann; Polina K Derevyanko; Kester Henningsen; Josephine Ann Mun Yee Choo; Valentina Manzini; Anna Magerhans; Celeste Giansanti; Christine M Eischen; Aart G Jochemsen; Matthias Dobbelstein
Journal:  Oncogene       Date:  2020-05-19       Impact factor: 9.867

4.  BAI1 regulates spatial learning and synaptic plasticity in the hippocampus.

Authors:  Dan Zhu; Chenchen Li; Andrew M Swanson; Rosa M Villalba; Jidong Guo; Zhaobin Zhang; Shannon Matheny; Tatsuro Murakami; Jason R Stephenson; Sarah Daniel; Masaki Fukata; Randy A Hall; Jeffrey J Olson; Gretchen N Neigh; Yoland Smith; Donald G Rainnie; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2015-03-09       Impact factor: 14.808

Review 5.  Future of Personalized Therapy Targeting Aberrant Signaling Pathways in Multiple Myeloma.

Authors:  Faiz Anwer; Kevin Mathew Gee; Ahmad Iftikhar; Mirza Baig; Atlantis Dawn Russ; Sabina Saeed; Muhammad Abu Zar; Faryal Razzaq; Jennifer Carew; Steffan Nawrocki; Hussam Al-Kateb; Nadia Nunes Cavalcante Parr; Ali McBride; Jason Valent; Christy Samaras
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2019-03-25

6.  Novel insights about the MDM2/MDM4 heterodimer.

Authors:  Fabiola Moretti
Journal:  Mol Cell Oncol       Date:  2015-08-20

7.  Characterization of cancer-associated missense mutations in MDM2.

Authors:  Krishna M Chauhan; Gopalakrishnan Ramakrishnan; Madhusudhan Kollareddy; Luis A Martinez
Journal:  Mol Cell Oncol       Date:  2015-12-10

8.  USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation.

Authors:  Sathish Kumar Mungamuri; Rui F Qiao; Shen Yao; James J Manfredi; Wei Gu; Stuart A Aaronson
Journal:  Cell Rep       Date:  2016-03-10       Impact factor: 9.423

9.  Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas.

Authors:  Jelena Todoric; Laura Antonucci; Giuseppe Di Caro; Ning Li; Xuefeng Wu; Nikki K Lytle; Debanjan Dhar; Sourav Banerjee; Johan B Fagman; Cecille D Browne; Atsushi Umemura; Mark A Valasek; Hannes Kessler; David Tarin; Michael Goggins; Tannishtha Reya; Maria Diaz-Meco; Jorge Moscat; Michael Karin
Journal:  Cancer Cell       Date:  2017-11-16       Impact factor: 31.743

10.  Prediction of protein disorder based on IUPred.

Authors:  Zsuzsanna Dosztányi
Journal:  Protein Sci       Date:  2017-11-16       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.